Literature DB >> 12464500

Newer experience with CPAP.

Richard A Polin1, Rakesh Sahni.   

Abstract

Progress in neonatal intensive care is closely linked to improvements in the management of respiratory failure in small infants. Current modalities of ventilatory assistance range from more benign continuous positive airway pressure (CPAP) to various modes of mechanical ventilation (including high frequency ventilation). The advent of less invasive methods of delivering CPAP has permitted earlier treatment of infants with respiratory distress syndrome and avoided the need for mechanical ventilation. Children's Hospital of New York (Columbia University) places all spontaneously breathing infants on nasal prong CPAP as the first mode of respiratory support. The early initiation of nasal prong CPAP in combination with a tolerance to elevated PCO(2) levels has reduced the incidence of chronic lung disease to <5% in infants weighing less than 1500g. This report will present an historical review and summarize the experience with CPAP at Columbia and other centres. In addition, it reviews the clinical applications and physiological effects of CPAP in preterm infants with respiratory distress syndrome.

Entities:  

Mesh:

Year:  2002        PMID: 12464500     DOI: 10.1053/siny.2002.0132

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  28 in total

1.  Gaseous distention of the hypopharynx and cervical esophagus with nasal CPAP: a mimicker of pharyngeal perforation and esophageal atresia.

Authors:  David Walor; Walter Berdon; Nicole Anderson; Peter D Holt; Matthew Fox
Journal:  Pediatr Radiol       Date:  2005-08-12

2.  Long-term outcome of preterm infants treated with nasal continuous positive airway pressure.

Authors:  Pia Wintermark; Jean-François Tolsa; Guy Van Melle; Margarita Forcada-Guex; Adrien C Moessinger
Journal:  Eur J Pediatr       Date:  2006-10-17       Impact factor: 3.183

Review 3.  Contribution of inflammation to lung injury and development.

Authors:  S G Kallapur; A H Jobe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03       Impact factor: 5.747

Review 4.  Weaning preterm infants from continuous positive airway pressure: evidence for best practice.

Authors:  Hesham Abdel-Hady; Basma Shouman; Nehad Nasef
Journal:  World J Pediatr       Date:  2015-04-06       Impact factor: 2.764

5.  Workplace NO and NO2 during combined treatment of infants with nasal CPAP and NO.

Authors:  Robert Lindwall; Mats E Svensson; Claes G Frostell; Staffan Eksborg; Lars E Gustafsson
Journal:  Intensive Care Med       Date:  2006-10-17       Impact factor: 17.440

6.  A new device for administration of continuous positive airway pressure in preterm infants: comparison with a standard nasal CPAP continuous positive airway pressure system.

Authors:  Daniele Trevisanuto; Nicoletta Grazzina; Nicoletta Doglioni; Paola Ferrarese; Francesco Marzari; Vincenzo Zanardo
Journal:  Intensive Care Med       Date:  2005-04-19       Impact factor: 17.440

7.  Sustainable use of continuous positive airway pressure in extremely preterm infants during the first week after delivery.

Authors:  C Booth; M H Premkumar; A Yannoulis; M Thomson; M Harrison; A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-07-04       Impact factor: 5.747

8.  The Effect of Extended Continuous Positive Airway Pressure on Changes in Lung Volumes in Stable Premature Infants: A Randomized Controlled Trial.

Authors:  Ryan Lam; Diane Schilling; Brian Scottoline; Astrid Platteau; Meike Niederhausen; Kelli C Lund; Robert L Schelonka; Kelvin D MacDonald; Cindy T McEvoy
Journal:  J Pediatr       Date:  2019-09-10       Impact factor: 4.406

Review 9.  Weaning of nasal CPAP in preterm infants: who, when and how? a systematic review of the literature.

Authors:  Shaili Amatya; Deepa Rastogi; Alok Bhutada; Shantanu Rastogi
Journal:  World J Pediatr       Date:  2014-12-29       Impact factor: 2.764

10.  Nasal continuous positive airway pressure and outcomes in preterm infants: A retrospective analysis.

Authors:  Gustavo Pelligra; Mohamed A Abdellatif; Shoo K Lee
Journal:  Paediatr Child Health       Date:  2008-02       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.